-
1
-
-
2542498920
-
What is the contribution of obesity to the metabolic syndrome?
-
Grundy SM. What is the contribution of obesity to the metabolic syndrome? Endocrinol Metab Clin North Am 2004 33 : 267 82.
-
(2004)
Endocrinol Metab Clin North Am
, vol.33
, pp. 267-82
-
-
Grundy, S.M.1
-
2
-
-
0141506880
-
Epidemic obesity and the metabolic syndrome
-
Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003 108 : 1541 5.
-
(2003)
Circulation
, vol.108
, pp. 1541-5
-
-
Haffner, S.1
Taegtmeyer, H.2
-
3
-
-
0037990061
-
The relationship of obesity to the metabolic syndrome
-
Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003 134 : 18 27.
-
(2003)
Int J Clin Pract Suppl
, vol.134
, pp. 18-27
-
-
Lebovitz, H.E.1
-
4
-
-
0027092522
-
Abdominal obesity and the metabolic syndrome
-
Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992 24 : 465 8.
-
(1992)
Ann Med
, vol.24
, pp. 465-8
-
-
Bjorntorp, P.1
-
5
-
-
10744233405
-
Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: Evidence supporting obesity as the central feature
-
Turkoglu C, Duman BS, Gunay D, Cagatay P, Ozcan R, Buyukdevrim AS. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg 2003 13 : 699 705.
-
(2003)
Obes Surg
, vol.13
, pp. 699-705
-
-
Turkoglu, C.1
Duman, B.S.2
Gunay, D.3
Cagatay, P.4
Ozcan, R.5
Buyukdevrim, A.S.6
-
6
-
-
0034595980
-
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
-
Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P, Derudas B et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 2000 275 : 16638 42.
-
(2000)
J Biol Chem
, vol.275
, pp. 16638-42
-
-
Guerre-Millo, M.1
Gervois, P.2
Raspe, E.3
Madsen, L.4
Poulain, P.5
Derudas, B.6
-
8
-
-
19944433634
-
Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance
-
Hung YJ, Hsieh CH, Pei D, Kuo SW, Lee JT, Wu LY et al. Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance. Clin Endocrinol (Oxf) 2005 62 : 85 91.
-
(2005)
Clin Endocrinol (Oxf)
, vol.62
, pp. 85-91
-
-
Hung, Y.J.1
Hsieh, C.H.2
Pei, D.3
Kuo, S.W.4
Lee, J.T.5
Wu, L.Y.6
-
9
-
-
0842263981
-
The biology of peroxisome proliferator-activated receptors: Relationship with lipid metabolism and insulin sensitivity
-
Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004 53 : S43 50.
-
(2004)
Diabetes
, vol.53
-
-
Ferre, P.1
-
10
-
-
13544256613
-
Peroxisome proliferator-activated receptors as attractive antiobesity targets
-
Zhang F, Lavan B, Gregoire FM. Peroxisome proliferator-activated receptors as attractive antiobesity targets. Drug News Perspect 2004 17 : 661 9.
-
(2004)
Drug News Perspect
, vol.17
, pp. 661-9
-
-
Zhang, F.1
Lavan, B.2
Gregoire, F.M.3
-
11
-
-
33644766913
-
PPARdelta regulates glucose metabolism and insulin sensitivity
-
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM et al. PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 2006 103 : 3444 9.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3444-9
-
-
Lee, C.H.1
Olson, P.2
Hevener, A.3
Mehl, I.4
Chong, L.W.5
Olefsky, J.M.6
-
12
-
-
23644445667
-
Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases
-
Bedu E, Wahli W, Desvergne B. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases. Expert Opin Ther Targets 2005 9 : 861 73.
-
(2005)
Expert Opin Ther Targets
, vol.9
, pp. 861-73
-
-
Bedu, E.1
Wahli, W.2
Desvergne, B.3
-
13
-
-
33644645013
-
PPAR delta: A dagger in the heart of the metabolic syndrome
-
Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 2006 116 : 590 7.
-
(2006)
J Clin Invest
, vol.116
, pp. 590-7
-
-
Barish, G.D.1
Narkar, V.A.2
Evans, R.M.3
-
14
-
-
0037022592
-
The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling
-
Shi Y, Hon M, Evans RM. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci USA 2002 99 : 2613 8.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 2613-8
-
-
Shi, Y.1
Hon, M.2
Evans, R.M.3
-
15
-
-
0037453718
-
Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity
-
Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H et al. Peroxisome- proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003 113 : 159 70.
-
(2003)
Cell
, vol.113
, pp. 159-70
-
-
Wang, Y.X.1
Lee, C.H.2
Tiep, S.3
Yu, R.T.4
Ham, J.5
Kang, H.6
-
16
-
-
8844276054
-
Regulation of muscle fiber type and running endurance by PPARdelta
-
Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004 2 : 1532 9.
-
(2004)
PLoS Biol
, vol.2
, pp. 1532-9
-
-
Wang, Y.X.1
Zhang, C.L.2
Yu, R.T.3
Cho, H.K.4
Nelson, M.C.5
Bayuga-Ocampo, C.R.6
-
17
-
-
0035942162
-
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
-
Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 2001 98 : 5306 11.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5306-11
-
-
Oliver Jr., W.R.1
Shenk, J.L.2
Snaith, M.R.3
Russell, C.S.4
Plunket, K.D.5
Bodkin, N.L.6
-
18
-
-
9144271149
-
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome
-
Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 2003 100 : 15924 9.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 15924-9
-
-
Tanaka, T.1
Yamamoto, J.2
Iwasaki, S.3
Asaba, H.4
Hamura, H.5
Ikeda, Y.6
-
19
-
-
10044224688
-
Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. a new target for the treatment of metabolic syndrome
-
Luquet S, Lopez-Soriano J, Holst DA, Gaudel C, Jehl-Pietri C, Fredenrich A et al. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. Biochimie 2004 86 : 833 7.
-
(2004)
Biochimie
, vol.86
, pp. 833-7
-
-
Luquet, S.1
Lopez-Soriano, J.2
Holst, D.A.3
Gaudel, C.4
Jehl-Pietri, C.5
Fredenrich, A.6
-
20
-
-
33646792244
-
Peroxisome proliferator-activated receptor delta (PPAR delta), a novel target site for drug discovery in metabolic syndrome
-
Takahashi S, Tanaka T, Kodama T, Sakai J. Peroxisome proliferator- activated receptor delta (PPAR delta), a novel target site for drug discovery in metabolic syndrome. Pharmacol Res 2006 53 : 501 7.
-
(2006)
Pharmacol Res
, vol.53
, pp. 501-7
-
-
Takahashi, S.1
Tanaka, T.2
Kodama, T.3
Sakai, J.4
-
21
-
-
0017142420
-
Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence
-
Holzwarth-McBride MA, Hurst EM, Knigge KM. Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence. Anat Rec 1976 186 : 185 205.
-
(1976)
Anat Rec
, vol.186
, pp. 185-205
-
-
Holzwarth-Mcbride, M.A.1
Hurst, E.M.2
Knigge, K.M.3
-
22
-
-
0015209505
-
Acute effect of oral and subcutaneous administration of monosodium glutamate on the arcuate nucleus of the hypothalamus in mice and rats
-
Burde RM, Schainker B, Kayes J. Acute effect of oral and subcutaneous administration of monosodium glutamate on the arcuate nucleus of the hypothalamus in mice and rats. Nature 1971 233 : 58 60.
-
(1971)
Nature
, vol.233
, pp. 58-60
-
-
Burde, R.M.1
Schainker, B.2
Kayes, J.3
-
23
-
-
0014668762
-
Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate
-
Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969 164 : 719 21.
-
(1969)
Science
, vol.164
, pp. 719-21
-
-
Olney, J.W.1
-
24
-
-
0035993394
-
Adrenalectomy abolishes the food-induced hypothalamic serotonin release in both normal and monosodium glutamate-obese rats
-
Guimaraes RB, Telles MM, Coelho VB, Mori RC, Nascimento CM, Ribeiro EB. Adrenalectomy abolishes the food-induced hypothalamic serotonin release in both normal and monosodium glutamate-obese rats. Brain Res Bull 2002 58 : 363 9.
-
(2002)
Brain Res Bull
, vol.58
, pp. 363-9
-
-
Guimaraes, R.B.1
Telles, M.M.2
Coelho, V.B.3
Mori, R.C.4
Nascimento, C.M.5
Ribeiro, E.B.6
-
26
-
-
0032566819
-
Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat
-
Morris MJ, Tortelli CF, Filippis A, Proietto J. Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat. Regul Pept 1998 75-76 : 441 7.
-
(1998)
Regul Pept
, vol.7576
, pp. 441-7
-
-
Morris, M.J.1
Tortelli, C.F.2
Filippis, A.3
Proietto, J.4
-
27
-
-
0024456675
-
Adrenalectomy prevents obesity in glutamate-treated mice
-
Tokuyama K, Himms-Hagen J. Adrenalectomy prevents obesity in glutamate-treated mice. Am J Physiol 1989 257 : E139 44.
-
(1989)
Am J Physiol
, vol.257
-
-
Tokuyama, K.1
Himms-Hagen, J.2
-
28
-
-
33745606757
-
The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats
-
Li PP, Shan S, Chen YT, Ning ZQ, Sun SJ, Liu Q et al. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol 2006 148 : 610 8.
-
(2006)
Br J Pharmacol
, vol.148
, pp. 610-8
-
-
Li, P.P.1
Shan, S.2
Chen, Y.T.3
Ning, Z.Q.4
Sun, S.J.5
Liu, Q.6
-
29
-
-
0031134821
-
Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake
-
Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 1997 30 : 671 4.
-
(1997)
Braz J Med Biol Res
, vol.30
, pp. 671-4
-
-
Hirata, A.E.1
Andrade, I.S.2
Vaskevicius, P.3
Dolnikoff, M.S.4
-
30
-
-
0034084335
-
Late Effects of Postnatal Administration of Monosodium Glutamate on Insulin Action in Adult Rats
-
Macho L, Ficková M, Ježová D, Zórad Š. Late Effects of Postnatal Administration of Monosodium Glutamate on Insulin Action in Adult Rats. Physiol Res 2000 49 (Suppl 1 S79 S85.
-
(2000)
Physiol Res
, vol.49
, Issue.1
-
-
MacHo, L.1
Ficková, M.2
Ježová, D.3
Zórad, Š.4
-
31
-
-
33645753739
-
GW-501516 GlaxoSmithKline/Ligand
-
Pelton P. GW-501516 GlaxoSmithKline/Ligand. Curr Opin Investig Drugs 2006 7 : 360 70.
-
(2006)
Curr Opin Investig Drugs
, vol.7
, pp. 360-70
-
-
Pelton, P.1
-
32
-
-
1542722295
-
11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
-
Wake DJ, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 2004 215 : 45 54.
-
(2004)
Mol Cell Endocrinol
, vol.215
, pp. 45-54
-
-
Wake, D.J.1
Walker, B.R.2
-
33
-
-
33745239304
-
Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver
-
Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 2006 6 : 177 81.
-
(2006)
Curr Diab Rep
, vol.6
, pp. 177-81
-
-
Boden, G.1
-
34
-
-
0037643536
-
Effects of free fatty acids (FFA) on glucose metabolism: Significance for insulin resistance and type 2 diabetes
-
Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003 111 : 121 4.
-
(2003)
Exp Clin Endocrinol Diabetes
, vol.111
, pp. 121-4
-
-
Boden, G.1
-
35
-
-
0035824440
-
A transgenic model of visceral obesity and the metabolic syndrome
-
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001 294 : 2166 70.
-
(2001)
Science
, vol.294
, pp. 2166-70
-
-
Masuzaki, H.1
Paterson, J.2
Shinyama, H.3
Morton, N.M.4
Mullins, J.J.5
Seckl, J.R.6
|